Cancer is still a leading cause of deaths worldwide, especially due to those cases
diagnosed at late stages with metastases that are still considered untreatable and are …

Background Longer time intervals to diagnosis and treatment are associated with worse
survival for various types of cancer. The patient, diagnostic, and treatment intervals are …

Health-care–related transportation insecurity is common in the United States. Patients with
cancer are especially vulnerable because cancer care is episodic in nature, occurs over a …

Introduction COVID-19 has disrupted the global health care system since March 2020. Lung
cancer (LC) patients (pts) represent a vulnerable population highly affected by the …

Introduction The COVID-19 pandemic had collateral effects on many health systems. Cancer
screening and diagnostic tests were postponed, resulting in delays in diagnosis and …

Simple Summary The number of gastrointestinal cancer patients declined during the COVID-
19 pandemic. In Japan, the number of early-stage gastric and colorectal cancer patients …

The increasing number of available anti-cancer drugs presents a challenge for oncologists,
who must choose the most effective treatment for the patient. Precision cancer medicine …

By 2040, the incidence of solid cancers among patients older than 70 years will increase
from 1.2 million to 2.2 million in North America alone. 1 Older adults with cancer are at …

Über viele Jahrzehnte war die komplette Ausräumung der axillären Lymphknoten im Sinne
einer Axilladissektion ein Standardverfahren in der Therapie des Mammakarzinom. Die …

This European Respiratory Society guideline is dedicated to the provision of good quality
recommendations in lung cancer care. All the clinical recommendations contained were …